McMillan Shakespeare Ltd (ASX: MMS) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
McMillan Shakespeare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
McMillan Shakespeare Ltd (ASX: MMS)
Latest News
⏸️ Investing
Why the Emerchants Ltd share price surged higher today
⏸️ Investing
Here's why these 4 ASX shares are soaring today
⏸️ Investing
2 under-the-radar dividend stars for your shopping list
⏸️ Investing
Which is the best salary packaging stock to buy today? (Part II)
⏸️ Investing
Which is the best salary packaging stock to buy today? (Part I)
⏸️ Investing
3 companies which doubled their dividends in the last 5 years
⏸️ Investing
Why the Lovisa Holdings Ltd share price soared today
⏸️ Investing
3 shares set to raise their dividends in FY 2017
⏸️ Investing
3 ASX shares near 52-week highs with room to run harder
⏸️ Investing
Why these 4 shares are climbing higher today
⏸️ Investing
Here's how Bill Shorten just sent these ASX shares rocketing
⏸️ Investing
Fairfax Media Limited & McMillan Shakespeare Limited: 2 shares that could rebound higher
Frequently Asked Questions
-
Yes, McMillan Shakespeare historically pays two fully franked dividends a year.
-
McMillan Shakespeare generally pays its shareholder dividends in March and September.
-
McMillan Shakespeare Ltd was listed on the ASX on 15 March 2004.
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 11 Sep 2025 | $0.7700 | 100.00% | Final | 26 Sep 2025 |
| 13 Mar 2025 | $0.7100 | 100.00% | Interim | 28 Mar 2025 |
| 12 Sep 2024 | $0.7800 | 100.00% | Final | 27 Sep 2024 |
| 07 Mar 2024 | $0.7600 | 100.00% | Interim | 22 Mar 2024 |
| 07 Sep 2023 | $0.6600 | 100.00% | Final | 22 Sep 2023 |
| 09 Mar 2023 | $0.5800 | 100.00% | Final | 24 Mar 2023 |
| 26 Oct 2022 | $0.7400 | 100.00% | Final | 10 Nov 2022 |
| 10 Mar 2022 | $0.3400 | 100.00% | Interim | 25 Mar 2022 |
| 09 Sep 2021 | $0.3110 | 100.00% | Final | 24 Sep 2021 |
| 11 Mar 2021 | $0.3020 | 100.00% | Interim | 26 Mar 2021 |
| 05 Mar 2020 | $0.3400 | 100.00% | Interim | 20 Mar 2020 |
| 28 Aug 2019 | $0.4000 | 100.00% | Final | 11 Sep 2019 |
| 07 Mar 2019 | $0.3400 | 100.00% | Interim | 22 Mar 2019 |
| 13 Sep 2018 | $0.4000 | 100.00% | Final | 28 Sep 2018 |
| 15 Mar 2018 | $0.3300 | 100.00% | Interim | 29 Mar 2018 |
| 28 Sep 2017 | $0.0000 | 100.00% | Final | 13 Oct 2017 |
| 30 Mar 2017 | $0.3100 | 100.00% | Interim | 13 Apr 2017 |
| 29 Sep 2016 | $0.3400 | 100.00% | Final | 14 Oct 2016 |
| 31 Mar 2016 | $0.2900 | 100.00% | Interim | 15 Apr 2016 |
| 16 Sep 2010 | $0.1400 | 100.00% | Final | 15 Oct 2010 |
| 08 Mar 2006 | $0.0250 | 100.00% | Interim | 29 Mar 2006 |
| 18 Aug 2005 | $0.0240 | 100.00% | Final | 16 Sep 2005 |
MMS ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About McMillan Shakespeare Ltd
McMillan Shakespeare Ltd (ASX: MMS) is an employee benefits provider. Its services include salary packaging, novated leasing, disability plan management and support coordination, asset management, and related financial products and services.
The company's asset management businesses provide motor vehicle leasing and fleet management services, as well as fleet and consumer financing.
McMillan Shakespeare consists of more than 20 subsidiaries, the majority incorporated in Australia but also in New Zealand and the United Kingdom.
MMS Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 13 Jan 2026 | $17.49 | $0.00 | 0.00% | 109,154 | $17.70 | $17.70 | $17.46 |
| 12 Jan 2026 | $17.49 | $0.03 | 0.17% | 103,798 | $17.51 | $17.80 | $17.40 |
| 09 Jan 2026 | $17.46 | $0.12 | 0.69% | 81,429 | $17.40 | $17.59 | $17.38 |
| 08 Jan 2026 | $17.34 | $0.13 | 0.76% | 68,884 | $17.24 | $17.34 | $17.12 |
| 07 Jan 2026 | $17.21 | $0.11 | 0.64% | 89,773 | $17.15 | $17.34 | $17.05 |
| 06 Jan 2026 | $17.10 | $0.19 | 1.12% | 103,644 | $17.05 | $17.23 | $16.93 |
| 05 Jan 2026 | $16.91 | $-0.25 | -1.46% | 120,681 | $17.20 | $17.34 | $16.86 |
| 02 Jan 2026 | $17.16 | $0.11 | 0.65% | 60,183 | $17.08 | $17.29 | $17.04 |
| 31 Dec 2025 | $17.05 | $0.14 | 0.83% | 79,887 | $16.92 | $17.18 | $16.92 |
| 30 Dec 2025 | $16.91 | $0.04 | 0.24% | 91,572 | $16.95 | $17.05 | $16.81 |
| 29 Dec 2025 | $16.87 | $0.00 | 0.00% | 75,025 | $16.88 | $17.01 | $16.80 |
| 24 Dec 2025 | $16.87 | $-0.23 | -1.35% | 36,340 | $17.16 | $17.21 | $16.87 |
| 23 Dec 2025 | $17.10 | $0.07 | 0.41% | 115,736 | $17.19 | $17.23 | $16.93 |
| 22 Dec 2025 | $17.03 | $0.21 | 1.25% | 97,721 | $16.90 | $17.04 | $16.70 |
| 19 Dec 2025 | $16.82 | $0.10 | 0.60% | 255,037 | $16.74 | $16.83 | $16.65 |
| 18 Dec 2025 | $16.72 | $0.27 | 1.64% | 66,388 | $16.51 | $16.78 | $16.41 |
| 17 Dec 2025 | $16.45 | $-0.03 | -0.18% | 72,614 | $16.40 | $16.58 | $16.23 |
| 16 Dec 2025 | $16.48 | $0.12 | 0.73% | 134,388 | $16.35 | $16.51 | $16.20 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 05 Dec 2025 | Robert (Rob) De Luca | Issued | 55,123 | $951,422 |
Director remuneration. 1,51,977 Rights
|
| 16 Sep 2025 | Robert (Rob) De Luca | Issued | 91,232 | $1,560,979 |
Conversion of securities.
|
| 16 Sep 2025 | Robert (Rob) De Luca | Exercise | 91,232 | $1,560,979 |
Conversion of securities. 99,583 Rights
|
| 16 Sep 2025 | Robert (Rob) De Luca | Transfer | 8,668 | $148,309 |
Off-market transfer. Assuming off market transfer of shares
|
| 16 Sep 2025 | Robert (Rob) De Luca | Transfer | 8,668 | $148,309 |
Off-market transfer. Assuming off market transfer of shares
|
| 16 Sep 2025 | Robert (Rob) De Luca | Expiry | 2,729 | $46,693 |
As advised by the company. Expired
|
| 12 Sep 2025 | Robert (Rob) De Luca | Issued | 5,884 | $104,441 |
Director remuneration. 1,90,815 Rights
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Bruce John Akhurst | Non-Executive Director | Apr 2021 |
Mr Akhurst is currently the Chair of the Peter McCallum Cancer Foundation. He was previously the Chairman and Director of Tabcorp Holdings Limited, CEO of Sensis, Group MD and General Counsel of Telstra, Partner of Mallesons Stephen Jaques, Council Member of RMIT University and a Director of Vocus Group Limited. He is a member of Member of Risk and Compliance Committee.
|
| Mr John G Bennetts | Non-Executive Director | Dec 2003 |
Mr Bennetts is an experienced investor and has been the founder and director of several successful Australian companies. He owns businesses in varied industries including technology and finance. He is a Non-Executive Director of Sacred Heart Mission. He was a founder of Cellestis Limited and private equity investment firm, Mooroolbark Investments Pty Limited (M-Group). He has also provided corporate advisory services to a range of companies in Australia and Asia.
|
| Mr Ross Chessari | Non-Executive Director | Dec 2003 |
Mr Chessari is a founder and director of the investment manager, SciVentures Investments Pty Limited (SciVentures). Prior to founding SciVentures, he was the Managing Director of ANZ Asset Management and the General Manager of ANZ Trustees.
|
| Ms Helen Kurincic | Non-Executive DirectorNon-Executive Chairman | Sep 2018 |
Ms Kurincic is a Non-Executive Director of Ramsay Health Care Limited and Carlton Football Club Limited. She has formerly held Board roles across the publicly listed, private, not-for profit and government sectors including Non-Executive Chair of Integral Diagnostics Limited, Non-Executive Director of Estia Health Limited, insurer HBF Health Limited, Domain Principal Group, DCA Group and Melbourne Health. She is a member of Member of Risk and Compliance Committee and People and Culture Committee.
|
| Ms Arlene May Tansey | Non-Executive Director | Nov 2022 |
Ms Tansey is a Non-Executive Director of Aristocrat Leisure Limited and La Trobe Financial (including La Trobe Private Credit Fund). She is also a Board member of the Australian National Maritime Museum and University of Wollongong Global Enterprises. She is a former Nonexecutive Director of TPG Telecom, Lendlease Investment Management, WiseTech Global Limited, Infrastructure NSW and the Australian Institute of Company Directors (NSW Division Council). She is Member of the Risk and Compliance Committee and Member of the People Culture Committee.
|
| Mr Robert (Rob) De Luca | Chief Executive OfficerManaging Director | May 2022 |
Mr De Luca joined MMS in May 2022 and has over 20 years' experience in the Financial Services, Wealth Management, Disability and Healthcare sectors, including roles as Managing Director of Bankwest, and CEO of the National Disability Insurance Agency (NDIA). Prior to joining MMS, he was CEO of Zenitas Healthcare.
|
| Ms Kathryn Maree Parsons | Non-Executive Director | May 2020 |
Ms Parsons is currently a Non-Executive Director of Nick Scali Limited and Shape Australia Corporation Limited. She has knowledge of accounting, finance, governance and risk management. Formerly an audit partner at Ernst & Young she worked in the firm's US, UK and Australian practices. In addition to her audit client responsibilities, she was part of the firm's Oceania Assurance Leadership team as the Professional Practice Director with responsibility for assurance quality and risk management in the region. She is Chair of the Risk and Compliance Committee and Member of the People and Culture Committee.
|
| Ms Michelle Siekierka | General CounselCompany Secretary | Oct 2025 |
-
|
| Michelle Siekierka | General CounselCompany Secretary |
-
|
|
| Mr P. Varro | Group Chief Financial Officer |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Aust) Ltd | 16,009,568 | 22.99% |
| Citicorp Nominees Pty Limited | 7,245,450 | 10.40% |
| Chessari Holdings Pty Ltd | 6,050,941 | 8.69% |
| J P Morgan Nominees Australia Pty Limited | 5,611,150 | 8.06% |
| Asia Pac Technology Pty Ltd | 3,068,025 | 4.41% |
| Ubs Nominees Pty Ltd | 1,377,875 | 1.98% |
| Ann Leslie Ryan | 1,008,418 | 1.45% |
| BNP Paribas Norns Pty Ltd | 569,534 | 0.82% |
| Mohl Invest Pty Ltd <Mohl Super Fund A/C> | 560,000 | 0.80% |
| Warbont Nominees Pty Ltd cUnpaid Entrepot A/C> | 476,686 | 0.68% |
| National Nominees Limited | 423,892 | 0.61% |
| HSBC Custody Nominees (Australia) Limited | 362,176 | 0.52% |
| Tarrina Holdings Pty Ltd cTarrina Holding S/F A/C> | 349,777 | 0.50% |
| BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 294,721 | 0.42% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 216,352 | 0.31% |
| Mestjo Pty Ltd | 214,790 | 0.31% |
| Mod Enterprises Pty Ltd | 193,139 | 0.28% |
| Birdseye No2 Management Pty Ltd <Birdseye Super No2 Fund A/C> | 160,000 | 0.23% |
| Isnf (Kn) Investments Pty Ltd clsnf Investments A/C> | 155,983 | 0.22% |
| Tn Terrigal Pty Ltd <Tn Terrigal A/C> | 155,983 | 0.22% |